Gellan gum injectable hydrogels for cartilage tissue engineering applications: In vitro studies and preliminary in vivo evaluation

Tissue Engineering - Part A

Volumn 16, Issue 1, 2010, Pages 343-353

  Oliveira, João T ^a   Santos, Tírcia C ^a   Martins, Luís ^b   Picciochi, Ricardo ^a   Marques, Alexandra P ^a   Castro, António G ^b   Neves, Nuno M ^a   Mano, João F ^a   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; BIOMECHANICS; BODY FLUIDS; CARTILAGE; COAGULATION; DYNAMIC ANALYSIS; DYNAMIC MECHANICAL ANALYSIS; ELECTRIC DISCHARGE MACHINING; EXPERIMENTS; GELATION; GELS; HYDROGELS; LIGAMENTS; MECHANICAL PROPERTIES; POLYMERASE CHAIN REACTION; RHEOLOGY; TISSUE ENGINEERING;

BALB/C MICE; BODY TEMPERATURE; CALCEIN; CARTILAGE TISSUE ENGINEERING; CARTILAGE TISSUES; CELL VIABILITY; CHONDROCYTES; COMPRESSION MODULUS; EXTRACELLULAR MATRICES; GELLAN GUM; HISTOLOGICAL ANALYSIS; HOST TISSUES; HUMAN ARTICULAR CHONDROCYTES; IN-SITU; IN-VITRO; IN-VIVO; INFLAMMATORY REACTION; INJECTABLE HYDROGELS; INJECTABLE SYSTEMS; LIVING ORGANISMS; PROCESSING METHOD; QUANTITATIVE POLYMERASE CHAIN REACTION; RHEOLOGICAL MEASUREMENTS; SIMPLE METHOD; SOL-GEL TRANSITIONS; TEMPERATURE DECREASE; WEIGHT MEASUREMENT;

IN SITU PROCESSING;

MUS;

BACTERIAL POLYSACCHARIDE; GELLAN;

ADULT; AGED; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIODEGRADABLE IMPLANT; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CYTOLOGY; EXTRACELLULAR MATRIX; FEMALE; FLOW KINETICS; HUMAN; HYDROGEL; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUSE; PHYSIOLOGICAL STRESS; TISSUE ENGINEERING;

ABSORBABLE IMPLANTS; ADULT; AGED; ANIMALS; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; EXTRACELLULAR MATRIX; FEMALE; HUMANS; HYDROGELS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL; RHEOLOGY; STRESS, PHYSIOLOGICAL; TISSUE ENGINEERING;

EID: 77049090031     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0117     Document Type: Article

References (45)

1. Hunt, S.A., Jazrawi, L.M., and Sherman, O.H. Arthroscopic management of osteoarthritis of the knee. J Am Acad Orthop Surg 10, 356, 2002.
2. Caplan, A.I., Elyaderani, M., Mochizuki, Y., Wakitani, S., and Goldberg, V.M. Principles of cartilage repair and regeneration. Clin Orthop Relat Res 342, 254, 1997.
3. Cancedda, R., Dozin, B., Giannoni, P., and Quarto, R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22, 81, 2003.
4. Ge, Z., Hu, Y., Heng, B.C., Yang, Z., Ouyang, H., Lee, E.H., and Cao, T. Osteoarthritis and therapy. Arthritis Rheum 55, 493, 2006.
5. Mano, J.F., and Reis, R.L. Osteochondral defects: present situation and tissue engineering approaches. J Tissue Eng Regen Med 1, 261, 2007.
6. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
7. Risbud, M.V., and Sittinger, M. Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol 20, 351, 2002.
8. Tuzlakoglu, K., Alves, C.M., Mano, J.F., and Reis, R.L. Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. Macro-mol Biosci 4, 811, 2004.
9. Lee, C.R., Breinan, H.A., Nehrer, S., and Spector, M. Articular cartilage chondrocytes in type I and type II collagen-GAG matrices exhibit contractile behavior in vitro. Tissue Eng 6, 555, 2000.
10. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529, 2000.
11. Stile, R.A., Burghardt, W.R., and Healy, K.E. Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro. Macromolecules 32, 7370, 1999.
12. Elisseeff, J., McIntosh, W., Anseth, K., Riley, S., Ragan, P., and Langer, R. Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 51, 164, 2000.
13. Drury, J.L., and Mooney, D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Bioma-terials 24, 4337, 2003.
14. Hoemann, C.D., Sun, J., Légaré, A., McKee, M.D., and Buschmann, M.D. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 13, 318, 2005.
15. Schagemann, J.C., Erggelet, C., Chung, H.W., Lahm, A., Kurz, H., and Mrosek, E.H. Cell-laden and cell-free bio-polymer hydrogel for the treatment of osteochondral defects in a sheep model. Tissue Eng Part A 15, 75, 2009.
16. Smith, A.M., Shelton, R.M., Perrie, Y., and Harris, J.J. An initial evaluation of gellan gum as a material for tissue engineering applications. J Biomater Appl 22, 241, 2007.
17. Oliveira, J.T., Picciochi, R., Santos, T.C., Martins, L., Pinto, L.G., Malafaya, P.B., Sousa, R.A., Marques, A.P., Castro, A.G., Mano, J.F., Neves, N.M., and Reis, R.L. Injectable gellan gum hydrogels as supports for cartilage tissue engineering applications. Annual Tissue Engineering and Regenerative Medicine International Society-European Chapter Meeting, Mary Ann Liebert Inc., Porto, Portugal, 2008, p. OP165.
18. Gong, Y., Wang, C., Lai, R.C., Su, K., Zhang, F., and Wang, D.-a. An improved injectable polysaccharide hydrogel: modified gellan gum for long-term cartilage regeneration in vitro. J Mater Chem 19, 1968, 2009.
19. Jansson, P.-E., Lindberg, B., and Sandford, P.A. Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea. Carbohydr Res 124, 135, 1983.
20. Moorhouse, R., Colegrove, G.T., Sandford, P.A., Baird, J.K., and Kang, K.S. PS-60: A New Gel-Forming Polysaccharide. Washington, DC: D.A. Brandt, 1981.
21. Rozier, A., Mazuel, C., Grove, J., and Plazonnet, B. Gelri-te(R): a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int J Pharm 57, 163, 1989.
22. Grasdalen, H., and Smidsrod, O. Gelation of gellan gum. Carbohydr Polym 7, 371, 1987.
23. Kang, K.S., and Veeder, G.T. Polysaccharide S-60 and bacterial fermentation process for its preparation. United States Patent 4326053 (1982).
24. Ogawa, E., Takahashi, R., Yajima, H., and Nishinari, K. Effects of molar mass on the coil to helix transition of sodium-type gellan gums in aqueous solutions. Food Hydrocoll 20, 378, 2006.
25. Oliveira, J.T., Martins, L., Picciochi, R., Malafaya, P.B., Sousa, R.A., Neves, N.M., Mano, J.F., and Reis, R.L. Gellan gum: a new biomaterial for cartilage tissue engineering applications, J Biomed Mater Res A, Aug 5, 2009 (Epub ahead of print).
26. Quinn, F.X., Hatakeyama, T., Yoshida, H., Takahashi, M., and Hatakeyama, H. The conformational properties of gellan gum hydrogels. Polym Gels Netw 1, 93, 1993.
27. Ogawa, E., Matsuzawa, H., and Iwahashi, M. Conformational transition of gellan gum of sodium, lithium, and potassium types in aqueous solutions. Food Hydrocoll 16, 1, 2002.
28. Miyoshi, E., Takaya, T., and Nishinari, K. Rheological and thermal studies of gel-sol transition in gellan gum aqueous solutions. Carbohydr Polym 30, 109, 1996.
29. Mao, R., Tang, J., and Swanson, B.G. Texture properties of high and low acyl mixed gellan gels. Carbohydr Polym 41, 331, 2000.
30. Coviello, T., Dentini, M., Rambone, G., Desideri, P., Carafa, M., Murtas, E., Riccieri, F.M., and Alhaique, F. A novel co-crosslinked polysaccharide: studies for a controlled delivery matrix. J Control Release 55, 57, 1998.
31. Kubo, W., Miyazaki, S., and Attwood, D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int J Pharm 258, 55, 2003.
32. Sanzgiri, Y.D., Maschi, S., Crescenzi, V., Callegaro, L., Topp, E.M., and Stella, V.J. Gellan-based systems for ophthalmic sustained delivery of methylprednisolone. J. Control Release 26, 195, 1993.
33. Crawford, A., and Dickinson, S.C. Chondrocyte isolation, expansion, and culture on polymer scaffolds, In: Hollander, A.P., and Hatton, P.V., eds. Methods in molecular biology: Biopolymer methods in tissue engineering. Totowa, NJ: Humana Press Inc., 238, 147, 2004.
34. AACT method. Methods 25, 402, 2001.
35. Page, D.C., and Lander, E.S. Available at http://frodo.wi.mit.edu/. 2008.
36. Froimson, M.I., Ratcliffe, A., Gardner, T.R., and Mow, V.C. Differences in patellofemoral joint cartilage material properties and their significance to the etiology of cartilage surface fibrillation. Osteoarthritis Cartilage 5, 377, 1997.
37. Nettles, D.L., Vail, T.P., Morgan, M.T., Grinstaff, M.W., and Setton, L.A. Photocrosslinkable hyaluronan as a scaffold for articular cartilage repair. Ann Biomed Eng 32, 391, 2004.
38. Hoffman, A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 54, 3, 2002.
39. Dickstein, K., Hapnes, R., and Aarsland, T. Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. Am J Ophthalmol 132, 626, 2001.
40. Weber, M., Steinert, A., Jork, A., Dimmler, A., Thurmer, F., Schütze, N., Hendrich, C, and Zimmermann, U. Formation of cartilage matrix proteins by BMP-transfected murine mesenchymal stem cells encapsulated in a novel class of alginates. Biomaterials 23, 2003, 2002.
41. Knudson, C.B., and Knudson, W. Cartilage proteoglycans. Semin Cell Dev Biol 12, 69, 2001.
42. Aigner, T., Gebhard, P.M., Schmid, E., Bau, B., Harley, V., and Pöschl, E. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 22, 363, 2003.
43. Tew, S.R., Clegg, P.D., Brew, C.J., Redmond, C.M., and Hardingham, T.E. SOX9 transduction of a human chon-drocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis. Arthritis Res Ther 9, R107, 2007.
44. Lefebvre, V., Li, P., and de Crombrugghe, B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. Embo J 17, 5718, 1998.
45. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A., and de Crombrugghe, B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16, 2813, 2002.